Pharmacokinetics of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat and dog

By McKillop D.   Partridge E. A.   Hutchison M.   Rhead S. A.   Parry A. C.   Bardsley J.   Woodman H. M.   Swaisland H. C.  

Xenobiotica, Vol. 34, Iss. 10, 2004-10 ,pp. : 901-915

Informa Healthcare

Access to resources Recommend Favorite

Ratiometric Assay of Epidermal Growth Factor Receptor Tyrosine Kinase Activation

By Schooler K.   Wiley H.S.  

Analytical Biochemistry, Vol. 277, Iss. 1, 2000-01 ,pp. : 135-142

Elsevier

Access to resources Recommend Favorite

Activation Mechanism of Solubilized Epidermal Growth Factor Receptor Tyrosine Kinase

By Ge G.   Wu J.   Wang Y.   Lin Q.  

Biochemical and Biophysical Research Communications, Vol. 290, Iss. 3, 2002-01 ,pp. : 914-920

Elsevier

Access to resources Recommend Favorite

A Basic Residue, Lys 782, Composes Part of the ATP-Binding Site on the Epidermal Growth Factor Receptor Tyrosine Kinase

By Klingbeil C.K.   Gill G.N.  

Archives of Biochemistry and Biophysics, Vol. 363, Iss. 1, 1999-03 ,pp. : 27-32

Elsevier

Access to resources Recommend Favorite

Effect of Membrane Fluidity on Tyrosine Kinase Activity of Reconstituted Epidermal Growth Factor Receptor

By Ge G.   Wu J.   Lin Q.  

Biochemical and Biophysical Research Communications, Vol. 282, Iss. 2, 2001-03 ,pp. : 511-514

Elsevier

Access to resources Recommend Favorite